IL325309A - סינתזה של מלחים של 2-(קרבמויוקסי)-n,n,n-טרימתילאתאנ-1-אמיניום - Google Patents
סינתזה של מלחים של 2-(קרבמויוקסי)-n,n,n-טרימתילאתאנ-1-אמיניוםInfo
- Publication number
- IL325309A IL325309A IL325309A IL32530925A IL325309A IL 325309 A IL325309 A IL 325309A IL 325309 A IL325309 A IL 325309A IL 32530925 A IL32530925 A IL 32530925A IL 325309 A IL325309 A IL 325309A
- Authority
- IL
- Israel
- Prior art keywords
- formula
- compound
- aspects
- cps
- mosm
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C269/00—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/12—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Ophthalmology & Optometry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202363508601P | 2023-06-16 | 2023-06-16 | |
| PCT/US2024/034043 WO2024259258A2 (en) | 2023-06-16 | 2024-06-14 | Synthesis of 2-(carbamoyloxy)-n,n,n-trimethylethan-1-aminium salts |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL325309A true IL325309A (he) | 2026-02-01 |
Family
ID=93852772
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL325309A IL325309A (he) | 2023-06-16 | 2024-06-14 | סינתזה של מלחים של 2-(קרבמויוקסי)-n,n,n-טרימתילאתאנ-1-אמיניום |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP4727533A2 (he) |
| KR (1) | KR20260023579A (he) |
| CN (1) | CN121548413A (he) |
| AU (1) | AU2024303954A1 (he) |
| CO (1) | CO2026000384A2 (he) |
| IL (1) | IL325309A (he) |
| WO (1) | WO2024259258A2 (he) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE129348T1 (de) * | 1989-10-13 | 1995-11-15 | Biocompatibles Ltd | Verfahren zur verminderung der absetzung von proteinen auf ophthalmologische geräte. |
| EP3522873B1 (en) * | 2016-10-04 | 2022-03-16 | Cellix Bio Private Limited | Compositions and methods for the treatment of xerostomia |
-
2024
- 2024-06-14 EP EP24824240.6A patent/EP4727533A2/en active Pending
- 2024-06-14 IL IL325309A patent/IL325309A/he unknown
- 2024-06-14 CN CN202480047460.1A patent/CN121548413A/zh active Pending
- 2024-06-14 KR KR1020267001383A patent/KR20260023579A/ko active Pending
- 2024-06-14 AU AU2024303954A patent/AU2024303954A1/en active Pending
- 2024-06-14 WO PCT/US2024/034043 patent/WO2024259258A2/en not_active Ceased
-
2026
- 2026-01-15 CO CONC2026/0000384A patent/CO2026000384A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20260023579A (ko) | 2026-02-20 |
| CO2026000384A2 (es) | 2026-02-02 |
| WO2024259258A3 (en) | 2025-06-12 |
| AU2024303954A1 (en) | 2026-01-29 |
| WO2024259258A2 (en) | 2024-12-19 |
| EP4727533A2 (en) | 2026-04-22 |
| CN121548413A (zh) | 2026-02-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100467898B1 (ko) | 티아졸리딘의 제조 방법 | |
| DE69606840T2 (de) | Monohydrate von Aminobenzensulfonsäurederivaten und Verfahren zu ihrer Herstellung | |
| US20230257412A1 (en) | Crystalline solids of nicotinic acid mononucleotide and esters thereof and methods of making and use | |
| AU2024203511A1 (en) | Manufacture of trans-[tetrachlorobis(1H-indazole)ruthenate (III)] and compositions thereof | |
| JP3215338B2 (ja) | アミノベンゼンスルホン酸誘導体一水和物及びその製造方法 | |
| IL325309A (he) | סינתזה של מלחים של 2-(קרבמויוקסי)-n,n,n-טרימתילאתאנ-1-אמיניום | |
| US8637515B2 (en) | Polymorphs of brimonidine pamoate | |
| US9580414B2 (en) | Salts and hydrates of antipsychotics | |
| WO2019218864A1 (zh) | 一种2-(α羟基戊基)苯甲酸的有机胺酯衍生物药物 | |
| NO165144B (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av interne salter av aminopyridiniumhydroksidog deres tilsvarende salter. | |
| US20120245346A1 (en) | Maleic acid salt and crystal thereof | |
| US20240262785A1 (en) | Solid Forms, Salts and Polymorphs of Anti-fibrotic Compounds | |
| US8816092B2 (en) | Indazole derivative or salt thereof and production intermediate thereof, and antioxidant using same, and use of indazole derivative or salt thereof | |
| EP3956287B1 (en) | Prodrugs of monomethyl fumarate | |
| JPH0733791A (ja) | 新規燐脂質誘導体、該燐脂質の製造法、該燐脂質の精製法、腫瘍並びに原生生物の疾病および真菌類の疾病の撲滅および自己免疫疾患、皮膚疾患、骨髄の損傷およびウイルス性疾患の治療のための医薬並びに該医薬の製造法 | |
| US20210002283A1 (en) | Benzodiazepine Derivative Hydrochloride and Crystal Form, Preparation Method and Application thereof | |
| EP2599772B1 (en) | Manufacturing method for aminoalkyl thiosulfuric acid compound | |
| US20240343757A1 (en) | Process for the preparation of budesonide 21-phosphate | |
| US20090069568A1 (en) | Method for producing indazol-3-ylmethyl phosphonium salt | |
| PT95731A (pt) | Processo para a preparacao de derivados da benzilpirrolidina uteis como agonistas da dopamina | |
| AU2022242950A1 (en) | Process for preparation of cabozantinib | |
| WO2023122842A1 (es) | Proceso para la preparación de apalutamida, intermediarios de sintesis y la dispersion solida amorfa que la contiene | |
| JP2001316381A (ja) | アミノベンゼンスルホン酸誘導体一水和物及びその製造方法 | |
| US20070099974A1 (en) | (R)-2-(4-amidinophenylaminomethyl)-1-methyl-5-[1-(carboxymethylamino)-1(pyrrolidinocarbonyl)-ethyl]-benzimidazole, the monohydrochloride thereof, preparation thereof and the use as pharmaceutical composition |